GLP-1 (glucagon-like peptide-1) receptor agonists are a powerful class of medications initially developed to manage type 2 diabetes. Today, they are transforming the landscape of non-surgical weight loss solutions.

A new weight loss treatment is on the horizon, and it’s set to redefine the way we manage obesity and metabolic health: Retatrutide.

Athletes, fitness enthusiasts, and high-performers are always looking for ways to optimize recovery, build strength, and enhance endurance.